Clinical Trial: A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older

U.S., March 25 -- ClinicalTrials.gov registry received information related to the study (NCT07489183) titled 'A Prospective, Open, Observational Study to Confirm the Lipid-lowering Effect, Changes in Glucose Metabolism, and Safety After 6 Months of Administration of Atostazet to Hypercholesterolemic Patients 65 Years of Age or Older' on March 19.

Brief Summary: A prospective, open, observational study to confirm the lipid-lowering effect, changes in glucose metabolism, and safety after 6 months of administration of atostazet to hypercholesterolemic patients 65 years of age or older

Study Start Date: Aug. 23, 2021

Study Type: OBSERVATIONAL

Condition: Hypercholesterolemia

Recruitment Status: COMPLETED

Sponsor: Dong Wha Pharmaceutical C...